MedTrace Logo

A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

NCT07572240 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-05-11

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the effects of AP-Brain collagen peptide on attention, focus, and memory in adults who are stressed but otherwise healthy.

The main questions it aims to answer are:

* How does AP-Brain affect a participant's attention, focus, stress, and memory?
* Is there a difference in the effects between a higher dose and a lower dose?
* What are the side effects, if any, for participants taking AP-Brain?

Researchers will compare two different doses of AP-Brain to see how they affect brain function and stress levels.

Participants in this study will be asked to:

* Take one of two the doses of AP-Brain once a day for 56 days.
* Visit the study center for regular checkups.
* Complete tasks that measure memory, focus, and attention.
* Answer survey questions about their stress levels.
* Provide blood samples and have vital signs checked.
* Have the brain's response to tasks monitored to see how it affects attention and alertness.

Conditions

  • Healthy
  • Stress

Interventions

DIETARY_SUPPLEMENT

AP-Brain Collagen Peptide

Single dose once daily

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    collaborator INDUSTRY

  • Rousselot BVBA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-18
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07572240 on ClinicalTrials.gov